Bloque 1
1. Pereira EA, Muthusamy KA, De Pennington N, et al: Deep brain stimulation of the pedunculopontine nucleus in Parkinson’s disease. Preliminary experience at Oxford. Br J Neurosurg 22 (1 Suppl):S41–S44, 2008
2. Stefani A, Lozano AM, Peppe A, et al: Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130:1596–1607, 2007
3. Kupsch A, Benecke R, Muller J, et al: Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 355:1978–1990, 2006
4. Coffey RJ: Deep brain stimulation for chronic pain: results of two multicenter trials and a structured review. Pain Med 2:183–192, 2001
Bloque 2
1.Protection against myocardial ischemia-reperfusion injury in clinical practice.Garcia-Dorado D,Rodríguez-Sinovas A,Ruiz-Meana M,Inserte JRev Esp Cardiol (Engl Ed).2014; 67(5):394-404.
2.Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
3.Carrasco-Chinchilla F, Muñoz-García AJ, Domínguez-Franco A, Millán-Vázquez G, Guerrero-Molina A, Ortiz-García C, Enguix-Armada A, Alonso-Briales JH, Hernández-García JM, de Teresa-Galván E, Jiménez-Navarro MF. Heart. 2013;99(19):1431-7.
4. Implante percutáneo de prótesis aórtica.Aortic-valve stenosis--from patients at risk to severe valve obstruction.Otto CM, Prendergast B. N Engl J Med. 2014;371(8):744-56.
5.Survival and predictive factors of mortality after 30 days in patients treated with percutaneous implantation of the CoreValve aortic prosthesis.Muñoz-García AJ, Hernández-García JM, Jiménez-Navarro MF, et al. Am Heart J. 2012;163(2):288-94.
Bloque 3
1. Gourin CG, Terris DJ. (2007). History of Robotic Surgery. En: Russell A Faust (ed.). Robotics in surgery: history, Current and Future Applications (1ª ed, pp 3 – 12). New York, EEUU:  Nova Science Publishers, Inc.
2. Sánchez-Martín F.M., Jiménez Schlegl P., Millán Rodríguez F., Salvador-Bayarri J., Monllau Font V., Palou Redorta J., Villavicencio Mavrich H. Historia de la robótica: de Arquitas de Tarento al Robot da Vinci (Parte II). Actas urológicas españolas 2007; 31 (3): 340 – 350.
3. Hockstein NG, Notan P, O´ Malley  BW Jr, Woo YJ. Robotic microlaryngeal surgery: a technical feasibility study using the da Vinci surgical robot and an airway mannequin. Laryngoscope. 2005. 115: 780-785.
4. Hockstein NG, Notan P, O´ Malley  BW Jr, Woo YJ. Robot assisted pharyngeal an laryngeal microsurgery: results of robotic cadaver dissections. Laryngoscope. 2005. 115: 1003-1008.
5. Wenstein GS, O´Malley BW Jr, Hockstein NG. Transoral robotic surgery: supraglottic laryngectomy in canine model. Laringoscope. 2005. 115: 1315-1319
6. O´ Malley BW Jr, Wenstein GS, Hockstein NG. Transoral robotic surgery (TORS): glottic microsurgery in a canine model. J. Voice. 2006. 20: 263-268
7. Wenstein GS, O´Malley BW Jr, Desai SC, Quon H. Transoal robotic surgery: does the end justify the means?. Head and Neck Oncology. 2009. 17: 126-131.
8. Patel VR. Essential elements to the establisment and design of a successful robotic surgery programme. Int J Med Robot. 2006. 2: 28-35
9. Chitwood WR Jr, Nifong LW, Chapman WH, et al. Robotic surgery training in an academic institution. Ann Surg. 2001. 234:475-478
10. Allona Almagro A, Platas Sancho A. Establecimiento de un programa en cirugía robótica en un hospital. Arch Esp Urol. 2007. 60 (4): 371-374
11. National  Academy of Sciences. Guide for the care and use of laboratory animals. DHHS Publication, NIH No 85-23 revised 1985
12. Fernandez-Nogueras FJ, Katati MJ,  Arraez Sanchez MA, Molina Martinez M, Sanchez Carrion M. Transoral robotic surgery of the central skull base: preclinical
investigations. Arch Otorhinolaryngol. 2013. DOI 10.1007s00405.013.2717-4
13. Fernandez-Nogueras FJ, Segura Fernandez-Nogueras M, Katati MJ, Arraez Sanchez MA, Roda Murillo O, Sanchez Montesinos I. Aplicabilidad del sistema da Vinci en el abordaje transoral a la base del cráneo. Investigación preclínica. Neurocirugía 2015. 26 (5): 217-223
14. Autorino R, Kahouk JH, Stolzenburg JU, Gill IS, Mottrie A, Tewari A, Cadeddu JA. Current status and future directions of robotic single-Site surgery: a systematic review. European Urology. 2013. 63: 266-280
Bloque 4
1. Flanigan DC, Harris JD, Trinh TQ et al. Prevalence of Chondral defects in athlete´s knee: A systematic review. Med Sci Sports Exerc. 2010; 42(10):1795-1801.
2. Mithoefer K, McAdams T, Scopp J,et al. Emerging options for treatment of articular cartilage injury in the athlete. Clin Sports Med. 2009; 28:25–40.
3. Pérez-Cachafeiro S, Ruano Raviña A, Couceiro Follente J et al . Spanish Experience in Autologous Chondrocyte Implantation. The Open Orthopaedics Journal
2010; 4: 14-21
4. Peterson L, Minas T, Brittberg M. et al. Treatment of Osteochondritis dissecans of the knee with autologous chondocyte transplantation. J Bone Joint Surg Am 2003; 85-A: S17-24.
5. Krishnan SP, Skinner JA, Carrington RW et al. Collagen covered autologous chondrocyte implantation for ostheochondritis disecans of the knee:two to seven years results. J Bone Joint Surg Br. 2006; 88(2): 203-205.
6. Couceiro J, Carpintero P, Silva MT. Cultivo de condrocitos. Rev Ortop Traumatol 2002; 5:436-443.
7.Jones DG, Peterson L. Autologous Chondrocyte Implantation. Instr Course Lect. 2007; 56:429-45
8. Concaro S, Nicklasson E, Ellowsson L. et al .Effect of cell seeding concentration on the quality of tissue engineered constructs loaded with adult human articular chondrocytes. J Tissue Eng Regen Med. 2008 Jan;2(1):14-21.
9. Brittberg M, Lindahl A, Nillson A et al Treatment of deep cartilage defects in the knee with autologouschondrocyte transplantation. N Engl J Med. 1994; 331: 889-95.
10. Aurich M, Anders J, Trommer T et al. Autologous chondrocyte transplantation by the sandwich techniquA salvage procedure for osteochondritis dissecans of the knee. Unfallchirurg. 2007 Feb;110(2):176-9
11. Barber-Westin SD, Noyes FR. Assessment of sports participation levels following knee injuries. SportsMed. 1999; 28:1-10.
12. Ware JE, Dewey JE, Perfetto RJ, enhttp://www. qualitymetric.com.
13. Niemeyer P, Pestka JM, Kreuz PC et al. Characteristic complications after autologous chondrocyte implantation for cartilage defects of the knee joint. Am J Sports Med 2008; 36(11):2091–2099
14. Wood JJ, Malek MA, Frassica FJ et al. Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration. J Bone Joint Surg Am 2006; 88(3):503–507
15. Kreuz PC, Steinwachs M, Erggelet C et al Classification of graft hypertrophy after autologous chondrocyte implantation of full-thickness chondral defects in the knee. Osteoarthr Cartil 2007; 15(12):1339–1347
16. Henderson I, Tuy B, Oakes B. Reoperation after autologous chondrocyte implantation. Indications and Þ ndings. J Bone Joint Surg Br 2004; 86(2):205–211
17. "Procedimiento de Implante de Condrocitos Autólogos” en Guía para trasplante de tejidos osteotendinosos. Sevilla 2008. Servicio Andaluz de Salud. Consejería de Salud. Junta de Andalucía. ISBN 978-84-691-6762-5. Depósito legal SE-5436-2008.
18. Bentley G, Bhamra JS, Panagiotis D et al Repair of osteochondral defects in joints – How to achieve success. Injury, Int. J. Care Injured 2013; 44: 3–10.
19. Minas T, Von Keudell A, Bryant T et al The John Insall Award: A Minimum 10-year Outcome Study of Autologous Chondrocyte Implantation. Clin Orthop Relat Res. 2013; Aug 24. PMID:23979923 En Edición
20. Pérez Cachafeiro S, Ruano Raviña A, Grupo de trabajo del trasplante autólogo de condrocitos. Implante autólogo de condrocitos: revisión sistemática y ampliación del seguimiento del uso tutelado. Madrid: Ministerio de Sanidad y Consumo. Avalia-t Nº 2006/05
21. Knutsen G, Drogset JO, Engebretsen L et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at Þ ve years. J Bone Joint Surg Am. 2007 Oct;89(10):2105-12.
22. Goyal D, Keyhani S, Lee EH et al. Evidence- Based Status of Microfracture Technique: A Systematic Review of Level I and II Studies. Arthroscopy. 2013 Sep;29(9):1579-88.
23. Kish G, Hangody L. A prospective, randomized comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br. 2004 May;86(4):619
24.Bader S, Miniaci A. Mosaïcplasty. Orthopedics. 2011 Sep 9;34(9):e491-3.
25.- Viste A, Piperno N, Desmarchelier R et al Autologous chondrocyte implantation for traumatic full-thickness cartilage defects of the knee in 14 patients: 6-year functional outcomes. Orthop & Traum: Surg & Res. 2012; (98) 7: 737–743
26. AignerT, Brittberg M, Bullough P et al. Histological Assessment of Chondrocyte Transplants. Pathology, Research and Practice; 2004: 200, 4.
27.- Longo UG, Forriol F, Maffulli N et al . Evaluation of histological scoring systems for tissue-engineered, repairedand osteoarthritic cartilage Osteoarthritis Cartilage 2010; 18(7):1001
28.- Brown WE, Potter HG, Marx RG et al. Magnetic resonance imaging appearance of cartilage repair in the knee. Clin Orthop Relat Res 2004; 422:214-23
29. Tins BJ, McCall IW, Takahashi T et al. Autologous chondrocyte implantation in knee joint: MR imaging and histologic features at 1-year follow-up. Radiology 2005; 234(2):501–508
30. Marlovits S, Singer P, Zeller P et al .Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol 2006; 57(1):16–23
31. Windt TS, Welsch GH, Brittberg M. et al. Is magnetic resonance imaging reliable in predicting clinical outcome after articular cartilage repair of the knee? A systematic review and meta-analysis. Am J Sports Med. 2013; 41(7):1695-702
32. Souza RB , Feeley BT, Zarins ZA et al.T1rho MRI relaxation in knee OA subjects with varying sizes of cartilage lesions. The Knee 2013; 20:113–119
33. Montañez-Heredia E, Garcia Vera JJ, Irízar S, Huertas P, Antúnez C,Hernandez-Lamas MC . El implante de condrocitos autólogos en la red sanitaria pública de Andalucía. Resultados tras 6 años.Rev. S. And. Traum. y Ort., 2013; 30 (2/2): 9-17
34. Montero-Vilchez T, Sierra-Sánchez Á, Sanchez-Diaz M, Quiñones-Vico MI, Sanabria-de-la-Torre R, Martinez-Lopez A, Arias-Santiago S. Mesenchymal Stromal Cell-Conditioned Medium for Skin Diseases: A Systematic Review. Front Cell Dev Biol. 2021 Jul 23;9:654210. doi: 10.3389/fcell.2021.654210.
35. Sierra-Sánchez Á, Kim KH, Blasco-Morente G, Arias-Santiago S. Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries. NPJ Regen Med. 2021 Jun 17;6(1):35. doi: 10.1038/s41536-021-00144-0.
36. Quiñones-Vico MI, Sanabria-de la Torre R, Sánchez-Díaz M, Sierra-Sánchez Á, Montero-Vílchez T, Fernández-González A, Arias-Santiago S. The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology. Front Cell Dev Biol. 2021 Apr 7;9:647012. doi: 10.3389/fcell.2021.647012.
37. Sierra-Sánchez Á, Montero-Vilchez T, Quiñones-Vico MI, Sanchez-Diaz M, Arias-Santiago S. Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases. Front Cell Dev Biol. 2021 Mar 9;9:643125. doi: 10.3389/fcell.2021.643125.
38. Cuenca-Barrales C, Molina-Leyva A, Arias-Santiago S. Potential role of human allogeneic mesenchymal cells in the treatment of refractory fistulas in patients with hidradenitis suppurativa. Dermatol Ther. 2021 Jan;34(1):e14548. doi: 10.1111/dth.14548. Epub 2020 Nov 21.
39. Sierra-Sánchez Á, Ordóñez-Luque A, Espinosa-Ibáñez O, Ruiz-García A, Arias-Santiago S. EpithelialIn vitroDifferentiation of Mesenchymal Stem Cells. Curr Stem Cell Res Ther. 2018;13(6):409-422. doi: 10.2174/1574888X13666180501120416.
40. Kim KH, Blasco-Morente G, Cuende N, Arias-Santiago S. Mesenchymal stromal cells: properties and role in management of cutaneous diseases. J Eur Acad Dermatol Venereol. 2017 Mar;31(3):414-423. doi: 10.1111/jdv.13934. Epub 2016 Sep 19.
41.Sierra-Sánchez Á, Barbier MA, Magne B, Larouche D, Arias-Santiago S, Germain L. Comparison of Two Human Skin Cell Isolation Protocols and Their Influence on Keratinocyte and Fibroblast Culture. Int J Mol Sci. 2023 Sep 28;24(19):14712. doi: 10.3390/ijms241914712.
42. Oualla-Bachiri W, Fernández-González A, Quiñones-Vico MI, Arias-Santiago S. From Grafts to Human Bioengineered Vascularized Skin Substitutes. Int J Mol Sci. 2020 Nov 2;21(21):8197. doi: 10.3390/ijms21218197.
